508
Views
2
CrossRef citations to date
0
Altmetric
Letters to the Editor: Original Scientific Contributions

A case of significant hypotension following a human ingestion of veterinary pimobendan

ORCID Icon, ORCID Icon & ORCID Icon
Pages 146-148 | Received 29 Jan 2019, Accepted 21 Apr 2019, Published online: 20 May 2019

References

  • Boyle KL, Leech E. A review of the pharmacology and clinical uses of pimobendan. J Vet Emerg Crit Care (San Antonio). 2012;22:398–408.
  • Lubsen J, Just H, Hjalmarsson AC, et al. Effect of pimobendan on exercise capacity in patients with heart failure: main results from the Pimobendan in Congestive Heart Failure (PICO) trial. Heart. 1996;76:223–231.
  • University of Otago. Toxinz; 2019. Available from: https://www.toxinz.com
  • Wylie CE, Cairns R, Brown JA, et al. Human exposures to veterinary pharmaceutical products reported to Australia’s largest Poison Information Centre. Clin Toxicol. 2019;1. doi:10.1080/15563650.2019.1572180
  • Chu KM, Shieh SM, Hu OYP. Pharmacokinetics and pharmacodynamics of enantiomers of pimobendan in patients with dilated cardiomyopathy and congestive heart failure after single and repeated oral dosing. Clin Pharmacol Ther. 1995;57:610–621.
  • Kuriya Si, Ohmori S, Hino M, et al. Identification of cytochrome P-450 isoform (s) responsible for the metabolism of pimobendan in human liver microsomes. Drug Metabol Dispos. 2000;28:73–78.
  • Hagemeijer F. Calcium sensitization with pimobendan: pharmacology, haemodynamic improvement, and sudden death in patients with chronic congestive heart failure. Eur Heart J. 1993;14:551–566.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.